eftilagimod alpha
immutep
['nsclc', 'eftilagimod', 'sclc']
if you enjoyed the talk by dario vignali on #lag3 and its inhibition during the #aacr23 session embracing immune ecosystems, check out this cancer discovery news in brief article on the benefit of the lag3 targeting drug eftilagimod alpha in #nsclc 
Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.